nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—PGD—blood plasma—acquired immunodeficiency syndrome	0.0249	0.18	CbGeAlD
Gadopentetate dimeglumine—PGD—retina—acquired immunodeficiency syndrome	0.0136	0.0984	CbGeAlD
Gadopentetate dimeglumine—PGD—skin of body—acquired immunodeficiency syndrome	0.012	0.0864	CbGeAlD
Gadopentetate dimeglumine—Gadobenate Dimeglumine—ALB—acquired immunodeficiency syndrome	0.0111	1	CrCbGaD
Gadopentetate dimeglumine—PGD—lymphoid tissue—acquired immunodeficiency syndrome	0.00969	0.0699	CbGeAlD
Gadopentetate dimeglumine—PGD—digestive system—acquired immunodeficiency syndrome	0.00957	0.0691	CbGeAlD
Gadopentetate dimeglumine—PGD—blood—acquired immunodeficiency syndrome	0.00912	0.0658	CbGeAlD
Gadopentetate dimeglumine—PGD—bone marrow—acquired immunodeficiency syndrome	0.00882	0.0637	CbGeAlD
Gadopentetate dimeglumine—PGD—spinal cord—acquired immunodeficiency syndrome	0.00878	0.0634	CbGeAlD
Gadopentetate dimeglumine—PGD—vagina—acquired immunodeficiency syndrome	0.00845	0.061	CbGeAlD
Gadopentetate dimeglumine—PGD—lung—acquired immunodeficiency syndrome	0.00799	0.0577	CbGeAlD
Gadopentetate dimeglumine—PGD—nervous system—acquired immunodeficiency syndrome	0.0074	0.0534	CbGeAlD
Gadopentetate dimeglumine—PGD—central nervous system—acquired immunodeficiency syndrome	0.00713	0.0514	CbGeAlD
Gadopentetate dimeglumine—PGD—brain—acquired immunodeficiency syndrome	0.00566	0.0408	CbGeAlD
Gadopentetate dimeglumine—PGD—lymph node—acquired immunodeficiency syndrome	0.00547	0.0395	CbGeAlD
Gadopentetate dimeglumine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000676	0.000795	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000675	0.000794	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000674	0.000793	CcSEcCtD
Gadopentetate dimeglumine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000673	0.000792	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000673	0.000792	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000673	0.000791	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000672	0.00079	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000672	0.00079	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000671	0.000789	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000669	0.000787	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000669	0.000787	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000668	0.000786	CcSEcCtD
Gadopentetate dimeglumine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000667	0.000785	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000666	0.000783	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000665	0.000782	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000665	0.000782	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000664	0.000781	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000663	0.000779	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000662	0.000778	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000662	0.000778	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00066	0.000776	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00066	0.000776	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000658	0.000774	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000658	0.000774	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000656	0.000771	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000656	0.000771	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000654	0.000769	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000653	0.000768	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000653	0.000768	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000652	0.000767	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000652	0.000766	CcSEcCtD
Gadopentetate dimeglumine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000651	0.000766	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000651	0.000765	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000647	0.000761	CcSEcCtD
Gadopentetate dimeglumine—Pain—Indinavir—acquired immunodeficiency syndrome	0.000647	0.000761	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000647	0.000761	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000647	0.00076	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000646	0.000759	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000644	0.000758	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000643	0.000757	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000643	0.000757	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000643	0.000756	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000642	0.000755	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000642	0.000755	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000641	0.000754	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000641	0.000754	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000639	0.000752	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000639	0.000751	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000638	0.00075	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000638	0.00075	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000636	0.000748	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000635	0.000747	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000635	0.000747	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000633	0.000745	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000631	0.000742	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000631	0.000742	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000626	0.000736	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000624	0.000734	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000624	0.000733	CcSEcCtD
Gadopentetate dimeglumine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000623	0.000732	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000622	0.000731	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000621	0.000731	CcSEcCtD
Gadopentetate dimeglumine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000621	0.000731	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000621	0.000731	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000621	0.00073	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000619	0.000728	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000619	0.000728	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000618	0.000726	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000618	0.000726	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000617	0.000725	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000617	0.000725	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000617	0.000725	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000615	0.000723	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000615	0.000723	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000614	0.000722	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000612	0.00072	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000612	0.000719	CcSEcCtD
Gadopentetate dimeglumine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000612	0.000719	CcSEcCtD
Gadopentetate dimeglumine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000612	0.000719	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000611	0.000719	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00061	0.000718	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00061	0.000718	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000608	0.000716	CcSEcCtD
Gadopentetate dimeglumine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000608	0.000715	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000606	0.000713	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000606	0.000713	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000604	0.00071	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000603	0.000709	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000602	0.000708	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000601	0.000707	CcSEcCtD
Gadopentetate dimeglumine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000599	0.000705	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000598	0.000704	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000598	0.000704	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000597	0.000703	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000597	0.000702	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000595	0.0007	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000595	0.0007	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000593	0.000697	CcSEcCtD
Gadopentetate dimeglumine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000592	0.000697	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000592	0.000696	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000592	0.000696	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000591	0.000695	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000591	0.000695	CcSEcCtD
Gadopentetate dimeglumine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000591	0.000694	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00059	0.000694	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00059	0.000694	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000589	0.000693	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000589	0.000693	CcSEcCtD
Gadopentetate dimeglumine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000589	0.000692	CcSEcCtD
Gadopentetate dimeglumine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000587	0.00069	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000587	0.00069	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000586	0.000689	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000585	0.000688	CcSEcCtD
Gadopentetate dimeglumine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000585	0.000688	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000585	0.000688	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000584	0.000687	CcSEcCtD
Gadopentetate dimeglumine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000582	0.000684	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000581	0.000684	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000581	0.000683	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000581	0.000683	CcSEcCtD
Gadopentetate dimeglumine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000578	0.00068	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000577	0.000678	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000576	0.000678	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000576	0.000677	CcSEcCtD
Gadopentetate dimeglumine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000572	0.000672	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00057	0.00067	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000569	0.000669	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000568	0.000668	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000568	0.000668	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000565	0.000665	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000565	0.000665	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000564	0.000664	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000564	0.000664	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000564	0.000663	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000563	0.000662	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000562	0.000661	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00056	0.000658	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000558	0.000656	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000558	0.000656	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000557	0.000655	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000556	0.000654	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000555	0.000653	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000554	0.000651	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.00055	0.000647	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000548	0.000645	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000547	0.000643	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000546	0.000643	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000546	0.000642	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000544	0.000639	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000543	0.000639	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000543	0.000639	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000543	0.000639	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000542	0.000637	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000541	0.000636	CcSEcCtD
Gadopentetate dimeglumine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000541	0.000636	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000541	0.000636	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000541	0.000636	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000538	0.000633	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000536	0.00063	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00053	0.000623	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000529	0.000623	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000527	0.00062	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000526	0.000618	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000525	0.000618	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000522	0.000614	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000522	0.000613	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000521	0.000613	CcSEcCtD
Gadopentetate dimeglumine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000521	0.000613	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000518	0.000609	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000518	0.000609	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000518	0.000609	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000518	0.000609	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000517	0.000608	CcSEcCtD
Gadopentetate dimeglumine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000513	0.000604	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000513	0.000604	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000513	0.000603	CcSEcCtD
Gadopentetate dimeglumine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00051	0.0006	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000506	0.000595	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000505	0.000594	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000504	0.000593	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000503	0.000591	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000502	0.00059	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000502	0.00059	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000501	0.000589	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000501	0.000589	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.0005	0.000588	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.0005	0.000588	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000498	0.000586	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000497	0.000584	CcSEcCtD
Gadopentetate dimeglumine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000497	0.000584	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000491	0.000577	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000489	0.000576	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000484	0.000569	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000484	0.000569	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000484	0.000569	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000482	0.000566	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000482	0.000566	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000481	0.000566	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000479	0.000563	CcSEcCtD
Gadopentetate dimeglumine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000477	0.000561	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000477	0.000561	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000475	0.000559	CcSEcCtD
Gadopentetate dimeglumine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000474	0.000558	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000473	0.000556	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000468	0.000551	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000466	0.000548	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000462	0.000543	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000459	0.00054	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000459	0.00054	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000455	0.000535	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000454	0.000534	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000453	0.000532	CcSEcCtD
Gadopentetate dimeglumine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000451	0.00053	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000451	0.00053	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00045	0.000529	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000449	0.000528	CcSEcCtD
Gadopentetate dimeglumine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000448	0.000527	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000448	0.000527	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000437	0.000514	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000435	0.000512	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000433	0.000509	CcSEcCtD
Gadopentetate dimeglumine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000432	0.000507	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000431	0.000507	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000431	0.000507	CcSEcCtD
Gadopentetate dimeglumine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000429	0.000504	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000428	0.000503	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000425	0.0005	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000418	0.000492	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000417	0.00049	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000417	0.00049	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000411	0.000483	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000407	0.000478	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000403	0.000474	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000402	0.000473	CcSEcCtD
Gadopentetate dimeglumine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000399	0.000469	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000399	0.000469	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000398	0.000468	CcSEcCtD
Gadopentetate dimeglumine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000396	0.000466	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000387	0.000455	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000384	0.000452	CcSEcCtD
Gadopentetate dimeglumine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000384	0.000452	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000384	0.000451	CcSEcCtD
Gadopentetate dimeglumine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000382	0.000449	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000376	0.000442	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000369	0.000435	CcSEcCtD
Gadopentetate dimeglumine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000366	0.000431	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000366	0.00043	CcSEcCtD
Gadopentetate dimeglumine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000364	0.000428	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000362	0.000426	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000345	0.000406	CcSEcCtD
